Markets
Canada Battles US Tariffs And Prepares For Economic Impact
Air Canada and Westjet aircraft (Artur Widak/Getty Images)

There are two ways in which tariffs are pushing down inflation. They’re both bad news.

Hotel prices in the Northeast are slumping, while West Texas Intermediate crude prices are at $60 per barrel.

Luke Kawa
4/10/25 1:09PM

There are a couple ways all the tariff talk and follow-through — which is poised to give prices an uncomfortable jolt higher — are having the opposite effect in some parts of the economy.

Here’s Omair Sharif, founder of Inflation Insights, with a crisp observation on a major surprise from this morning’s March consumer price inflation report: a relatively small rise in hotel prices.

“The 1.0% non-seasonally adjusted rise was the weakest since March 2020, and excluding that, it was the weakest in any March since 1992,” he wrote. “However, this does not look to be broad-based cyclical weakness and instead looks to have been centered in the Northeast, perhaps reflecting wariness about US travel among Canadians and other international visitors.”

Hotel Rates Northeast
Source: Inflation Insights

Sherwood News’ Max Knoblauch has reported that, as of late March, airline bookings from April through September for cross-border travel between Canada and the United States have plummeted by more than 70%. That’s a precipitous decline from the country that’s the top source of international visitors.

Canadians have been (understandably) ticked off not only by tariffs, but also President Trump’s threats against the nation’s sovereignty. It goes without saying that a decline in tourism would be a clear negative for economic activity.

“It is possible, although far from certain given the typical volatility in this index, that lower demand from foreign travelers, including Canadians, could be hitting the Northeast region a bit harder than other areas,” Sharif added.

Of course, the much larger way that tariffs will bring some disinflation to offset some of the looming upward pressure on prices comes from oil, which has cratered amid demand fears and OPEC+’s plan to return barrels to market. The declines have been so severe that some analysts are warning that US oil producers might start cutting production.

More Markets

See all Markets
markets

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.